Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PCRX | Pacira BioSciences | $0.62 | $0.60 | — | — | $167.12M | $175.88M | — | — | 05/06/2025 | Get Alert |
PCRX | Pacira BioSciences | $0.89 | $0.83 | $0.91 | 9.64% | $181.24M | $185.38M | $187.25M | 1.01% | 02/27/2025 | Get Alert |
PCRX | Pacira BioSciences | $0.72 | $0.70 | $0.79 | 12.86% | $163.93M | $169.67M | $168.57M | -0.65% | 11/06/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.78 | $0.70 | $0.89 | 27.14% | $169.47M | $172.48M | $178.02M | 3.21% | 07/30/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.62 | $0.62 | 0.00% | $160.34M | $165.35M | $167.12M | 1.07% | 05/07/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.80 | $0.88 | $0.89 | 1.14% | $171.96M | $181.66M | $181.24M | -0.23% | 02/29/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.64 | $0.79 | $0.72 | -8.86% | $167.47M | $173.00M | $163.93M | -5.25% | 11/02/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.51 | $0.81 | $0.78 | -3.70% | $169.41M | $175.64M | $169.47M | -3.51% | 08/02/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.64 | $0.62 | $0.53 | -14.52% | $157.99M | $158.84M | $160.34M | 0.94% | 05/03/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.97 | $0.83 | $0.80 | -3.61% | $159.19M | $173.50M | $171.96M | -0.89% | 02/28/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.72 | $0.76 | $0.64 | -15.79% | $127.72M | $168.89M | $167.47M | -0.84% | 11/03/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.77 | $0.88 | $0.51 | -42.05% | $135.59M | $171.43M | $169.41M | -1.18% | 08/03/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.83 | $0.64 | -22.89% | $119.03M | $159.49M | $157.99M | -0.94% | 05/04/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.87 | $0.90 | $0.97 | 7.78% | $130.97M | $155.74M | $159.19M | 2.22% | 02/24/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.68 | $0.65 | $0.72 | 10.77% | $117.48M | $130.38M | $127.72M | -2.04% | 11/03/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.12 | $0.69 | $0.77 | 11.59% | $75.50M | $128.01M | $135.59M | 5.92% | 08/03/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.63 | $0.53 | -15.87% | $105.68M | $119.28M | $119.03M | -0.21% | 05/04/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.56 | $0.81 | $0.87 | 7.41% | $122.42M | $131.57M | $130.97M | -0.45% | 02/25/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.48 | $0.61 | $0.68 | 11.48% | $104.69M | $115.15M | $117.48M | 2.03% | 10/29/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.41 | $0.09 | $0.12 | 33.33% | $102.60M | $72.46M | $75.50M | 4.20% | 08/06/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.22 | $0.32 | $0.53 | 65.62% | $91.31M | $102.97M | $105.68M | 2.64% | 05/07/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.91 | $0.83 | 9.64 % |
Q3 | 2024-11-06 | $0.79 | $0.70 | 12.9 % |
Q2 | 2024-07-30 | $0.89 | $0.70 | 27.1 % |
Q1 | 2024-05-07 | $0.62 | $0.62 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $187.25M | $185.38M | 1.01 % |
Q3 | 2024-11-06 | $168.57M | $169.67M | -0.65 % |
Q2 | 2024-07-30 | $178.02M | $172.48M | 3.21 % |
Q1 | 2024-05-07 | $167.12M | $165.35M | 1.07 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.91, which beat the estimate of $0.83.
The Actual Revenue was $187.3M, which beat the estimate of $185.4M.
Browse earnings estimates, EPS, and revenue on all stocks.